Phycocyanin Market Analysis

Grade Segment Analysis

Based on grade, the pharmaceutical grade segment is projected to garner the largest revenue share of 42.4% during the forecast duration. The growing body of research into its therapeutic potential, particularly for its anti-inflammatory and antioxidant effects. For instance, in February 2025, Pholoho Biotechnology announced a breakthrough in producing reagent-grade, high-purity C-Phycocyanin for cancer research applications, which are the signaling factors for growing momentum for pharmaceutical-grade phycocyanin, encouraging opportunities beyond food and cosmetics into high-value biopharma sectors.

Application Segment Analysis

In terms of application nutraceuticals & foods & beverages segment is predicted to attain a share of 35.7% by the end of 2035. The growth in the segment is highly subject to the shift towards natural ingredients and clean-label products. For instance, in November 2022, GNT reported that it secured the U.S. FDA approval for the use of its spirulina-based EXBERRY Blue Beverage Solution across a wide range of non-alcoholic and low-ABV drinks. Hence, this milestone enables a stable and natural blue coloring in acidic beverages, thereby reinforcing spirulina’s role in future functional drink innovations.

Form Segment Analysis

Based on the form powder segment is anticipated to capture a remarkable share of 28.5% during the analyzed time frame. Its superior stability, longer shelf life, and high concentration make it preferable for wider utilization in tablets, powders, and protein powder blends. On the other hand, factors such as logistical efficiency and versatility in manufacturing processes are also solidifying the subtype’s position in this field. Additionally, the heightened demand for convenient, easy-to-use natural ingredients in the food and nutraceutical industries is further driving the adoption of phycocyanin powder.

Our in-depth analysis of the global market includes the following segments: